Unpacking Endometrial Cancer with Professor Linda Mileshkin
Endometrial cancer is the most common gynaecological cancer in Australia and advanced disease and early…
Browsing: Featured Events
ASH 2023: New drug helps narrow racial survival disparity in patients with acute myeloid leukaemia
Non-Hispanic Black patients with acute myeloid leukaemia (AML) are living longer, now that new therapies are available,…
SABCS 2023: Tucatinib plus trastuzumab emtansine may benefit patients with advanced or metastatic HER2-positive breast cancer
A combination of two HER2-targeted drugs, tucatinib (Tukysa) and trastuzumab emtansine (Kadcyla, T-DM1), extended progression-free…
SABCS 2023: Exercise may boost quality of life for patients with metastatic breast cancer
Among patients with metastatic breast cancer, those who took part in a nine-month structured exercise…
AGITG 2023 Wrap-Up with Katie Garman and Ben Lawrence
How can we change our inner worlds alongside our healthcare systems? How can we integrate…
ABC 7: Aid agencies are failing patients with breast cancer in war zones meaning more will develop advanced disease
Patients with breast cancer in conflict zones around the world are being “massively under-served” by…
COSA 2023: Cancer’s unspoken financial burden
“Many Australians affected by cancer experience a significant financial burden, which can lead to physical…
COSA 2023: Fertility preservation and cancer
Having a baby is a realistic aspiration for young women undergoing cancer treatment but fertility…
ESMO 2023: Lung cancer treatment research enters a new era
More people with non-small cell lung cancer (NSCLC) are likely to benefit from new drugs…
ESMO 2023: Advances in gynaecological cancer research could change the treatment landscape
Results from highly anticipated phase 3 clinical trials in gynaecological cancers with, among others, new…